When localised breast cancer is identified at an early stage, it is curable. Rising attendance in mammography screening programmes attest to the fact that women have gotten that message. However, the resulting workload increase is a growing challenge for many women’s imaging centres. At the 2025 SBI (Society of Breast Imaging) Symposium in Colorado Springs, USA, breast imaging specialist…
Researchers have developed a tool to quickly quantify changes in the branches of mouse mammary glands. This could one day be used to detect early warning signs of breast cancer.
Using AI to help detect one of the leading killers of women worldwide: A new machine learning model can successfully predict heart disease risk in women by analysing mammograms.
AI may be effective at detecting advanced breast cancer in mammograms, but current models still lack reliability. New research from Korea suggests that up to 14% of invasive cases are missed.
Mammography image interpretation AI models are unreliable – but so are human readers. A new hybrid strategy could reduce radiologist workload by 38% without compromising diagnostic efficacy.
More clinically relevant tumors detected at an earlier stage and at lower costs: New research finds that AI can replace the second radiologist in the Dutch breast cancer screening program.
When should preventive mastectomy be offered for women at higher risk of breast cancer? A new evaluation model defines thresholds at which risk reducing surgery should be recommended.
Dense calcifications are common in breast tissue, but not every finding in a mammogram is a precursor of cancer. New insights could lead to fewer benign biopsies and guide therapeutic development.
RadNet's DeepHealth unit has completed its acquisition of iCAD, adding established AI breast cancer detection capabilities to its diagnostic platform.
By directing radiologists' attention to potentially suspicious areas, AI can help spot more lesions indicative of breast cancer in mammograms. This is suggested by a new study.
Many women are only diagnosed with breast cancer after they present to a doctor with symptoms. A new study points out that early detection through screening leads to improved outcomes.
Diagnosing breast cancer in women with extremely dense breasts often comes down to MRI, but the scans take long and are expensive. Research confirms that shorter protocols also yield accurate results.
Using radiomics on mammograms of over 30,000 women, researchers have identified six breast texture patterns that may be associated with increased cancer risk.
A novel deep-learning approach automatically finds and classifies microcalcifications found in mammography images—bringing both accuracy and consistency to breast-cancer screening.
At the San Antonio Breast Cancer Symposium (SABCS), three experts presented new approaches and study results for the treatment of breast cancer in young women.
Despite their improving diagnostic accuracy, medical AI systems are often met with skepticism by radiologists. Their patients, however, seem more inclined to embrace this technology, a study shows.
New findings show how AI-assisted mammography may not only reveal breast cancer, but can also assess calcium buildup in the arteries within breast tissue—an indicator of cardiovascular health.
AI-supported screening for breast cancer can detect more cancer cases compared with traditional screening, and find more invasive cancers at an early stage, results from the MASAI trial indicate.
Improved breast cancer detection, reduced workload for radiologists: The world’s largest prospective study on AI in Germany’s Mammography Screening Program reveals the technology's benefits.
In the world of theatre, the ‘deus ex machina’, the god from the machine, is a dramaturgical trick to resolve seemingly unsolvable conflicts. Can artificial intelligence (AI) also be such a universal problem solver for internal medicine? At the Annual Congress of the German Society of Internal Medicine (DGIM), Dr Isabella Wiest explored the potential – and limitations – of AI helpers.
Measuring the calcium build up in the arteries of the breast, researchers have developed an AI-generated score for predicting cardiovascular disease in women from their mammograms.
Evidence of the superiority of tomosynthesis for breast cancer detection is stacking up, with new results from a 10-year study further demonstrating the 3D imaging technique's benefits.
Mammography can lead to “false positives,” meaning they do not result in a breast cancer diagnosis. This may discourage some women from future screenings, according to a new study.
Radiologists and gynaecologists entered a veritable bout during the Oxford debate at the 43rd annual congress of the German Senologic Society in Dresden. Controversy was sparked by the question of whether all patients with a ductal carcinoma in situ (DCIS) should undergo radiotherapy.
Interdisciplinary collaboration between gynaecologists, radiologists, pathologists and breast care nurses following a palpation finding makes a decisive contribution to the success of further breast cancer treatment. This was the consensus among the speakers at the Annual Congress of the German Society of Senology in Dresden. The experts provided clear explanations of which imaging is best for…
Researchers have developed an artificial intelligence which can differentiate cancer cells from normal cells, as well as detect the very early stages of viral infection inside cells.
Although the Covid-19 pandemic is behind us, healthcare facilities continue to experience workflow challenges and resource constraints impacting women’s health and a patient’s ability to receive a timely diagnosis. Clinical specialties like breast radiology and cytology are especially susceptible to these issues and continue to experience backlogs, which impact their ability to deliver timely…
Using artificial intelligence (AI), breast radiologists in Denmark have improved breast cancer screening performance and reduced the rate of false-positive findings.
Current AI systems for detecting breast cancer from mammography exams are more likely to produce false-positive results in black women and older patients, a new study finds.
A team of Danish and Dutch researchers has combined an AI diagnostic tool with a mammographic texture model to improve the assessment of short- and long-term breast cancer risk. This new approach represents a significant step forward in refining the ability to predict the complexities of breast cancer risk.
A clinical trial has revealed the effectiveness of '3D mammography' in reducing by almost half the incidence of interval breast cancer appearing between two rounds of screening.
A combination of PET and MR imaging could help doctors spot signs that breast cancer is beginning to spread in a patient. This insight can then be used to adapt treatment strategies.
Hologic, Inc. unveils new research in artificial intelligence (AI) and offering innovative educational opportunities at the annual European Congress of Radiology (ECR) in Vienna, Austria.
Breast MRI is increasingly being used as a primary breast cancer screening exam for young women. It brings benefits in women with dense breasts, who are at an elevated risk of developing breast cancer. The technique is also being ordered as a supplemental screening exam following mammography or breast ultrasound for women of all ages at high risk. But use of breast MRI as a screening tool is…
A newly-developed biosensor could be an alterative to MRI and mammography for breast cancer screening. The handheld device uses saliva on test strips to determine whether cancer is present.
A new breast imaging technique provides high sensitivity for detecting cancer while significantly reducing the likelihood of false positive results, according to a new study.
Researchers in Singapore have developed an AI-based software to assist in the early detection of breast cancer. Using thermal imaging, the program assesses the malignancy of a tumour.
While having more centers adopt digital breast tomosynthesis (DBT) for breast cancer screenings into their practice is a positive change, it also presents some challenges for radiologists—particularly the increased number of images for radiologists to review. This challenge has paved the way for AI to offer innovative workflow solutions for radiologists that do not sacrifice accuracy.
Mammographic screening is used to detect breast cancer, but is prone to false findings. Could an AI reader help improve this? UK researchers compared the performance of man and machine.
Can per- and polyfluoroalkyl substances (PFAS) increase the risk of breast cancer? A new study by US researchers examines the effects of the so-called “forever chemicals”.
A new safety analysis finds AI-supported mammography analysis is as good as two breast radiologists working together to detect breast cancer, almost halving the screen-reading workload.
With the recent recommendation changes from the European Council in 2022, how radiologists screen for breast cancer is changing. Mammography has long been an essential technology in screening for breast cancer, and in the recommendations the Council formally recognized the advantages of digital breast tomosynthesis (DBT). This landmark acknowledges the research on and benefits of DBT, advocating…
A new device, designed by MIT researchers, could detect breast cancer earlier. The scanner, which can be incorporated into a bra, could allow more frequent monitoring of high-risk patients.
Mammography has been an essential imaging technology for breast cancer detection for decades. As the industry has continued to innovate, one advancement in mammography has particularly changed the landscape of breast imaging: digital breast tomosynthesis (DBT), also known as 3D mammography.
Ultrasound is an effective standalone diagnostic method in patients with focal breast complaints, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA). Focal breast complaints can refer to pain, lumps, nipple discharge or other symptoms and conditions confined to a specific area of the breast.
As ChatGPT becomes more popular among those seeking health advice, researchers try to find out whether the information provided by the AI chatbot is reliable and accurate.
In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone.
Compared to other common supplemental screening methods, breast MRI was superior at detecting breast cancer in women with dense breasts, according to a new study.
The need for breast cancer screening of transgender individuals has been a topic of uncertainty until recently, due to lack of reliable patient data, consensus by radiologists, published research, and recommended guidelines. A 2021 survey of Society of Breast Imaging (SBI) members revealed that ‘breast radiologists differ in their practice and knowledge regarding screening of transgender…
The risk of developing breast cancer is higher in breasts with high density. But why is that? Researchers at Linköping University have shown major biological differences that promote cancer growth.
Women with high-risk breast lesions (HRLs) and no family history of breast cancer or BRCA mutations are generally considered to be at moderate risk of developing breast cancer. Breast cancer screening guidelines suggest breast MRI be considered as a supplement to mammography. But is this expensive exam necessary?
When double reading screening mammograms, radiographers trained for the task perform as well as radiologists in key areas, according to a new publication.
The interplay between the patient’s BMI, tumour size and cancer-specific proteins is of importance for the prognosis of breast cancer, a study from Sweden shows.
Clinical laboratories need to be proactive to attract transgender patients for testing and to ensure that they are comfortable with the services provided. This issue is of great importance to the American Association for Clinical Chemistry (AACC), which conducted a scientific session on transgender health at its recent annual meeting in Chicago.
Contrast-enhanced mammography (CEM) has gone a long way since it was first approved by the Food and Drug Administration (FDA) in 2011. An Italian expert explained how useful the modality has become in breast imaging in a dedicated course at ECR 2022.
A major new study shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programs.
A software based on deep learning with convolutional neural networks can accurately and consistently classify breast density on mammograms according to BI-RADS criteria.
Annual MRI screenings starting at ages 30-35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a new modeling analysis.
Artificial intelligence (AI) models that evaluate medical images have potential to speed up and improve accuracy of cancer diagnoses, but they may also be vulnerable to cyberattacks.
Artificial intelligence (AI) is changing our healthcare systems. It can help us detect diseases earlier, improve patient care and reduce healthcare costs. However, there is still a lack of trust, of rules and safety regulations and of broad data pools. How can we use AI successfully in healthcare systems and what role will it play in the future?
Mammograms are a safe, effective way to detect the presence of breast cancer in women. But doctors recommend most females should start getting mammograms after the age of 40 in part because the procedure involves small doses of ionizing radiation. While the risk of getting breast cancer is higher for older people, it can strike at any age. Studies show that 5% to 7% of females with breast cancer…
How will digital technology impact healthcare in 2030? If challenges to acceptance and utilisation can be overcome, healthcare providers and patients will benefit significantly, according to physicians participating in a recent online seminar on this topic.
Contact shielding is one of the most divisive areas in radiography. Is it still essential in protecting patients from radiation, or has new technology made this precaution obsolete? Two experts debated the issue at the ISRRT congress in Dublin.
The Covid-19 pandemic continues to impact people’s health across the world. This goes beyond the disease itself, as healthcare systems adapt how they provide services. Routine screening has been severely affected with screening programmes reduced or paused.
The contribution of Artificial intelligence (AI) has great potential in breast imaging efficiency, Professor Linda Moy MD told attendees at the 2021 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium this April. AI models for breast imaging have focused mainly on the diagnostic classification and detection of breast cancer.
In just the last two years, artificial intelligence has become embedded in scores of medical devices that offer advice to ER doctors, cardiologists, oncologists, and countless other health care providers. But how much do either regulators or doctors really know about the accuracy of these tools? A new study led by researchers at Stanford, some of whom are themselves developing devices, suggests…
Medical technology company iCAD, Inc. announced that ProFound AI for 2D Mammography might notably reduce the risk of interval breast cancer, according to a new retrospective analysis. The aim of the study was to determine if adding AI to reading mammography as a supportive tool may help in decreasing the interval cancer rate in population-based organized mammography screening programs in Germany.
One of the leading figures in global radiology has highlighted the importance of fostering a strong eco-system to advance the safe and effective implementation of AI in medical imaging. Dr Geraldine McGinty said that to fully leverage the power of AI, all stakeholders must work together but underlined the unique responsibility physicians have to ensure patient interests are best served.
Implementation of artificial intelligence into Scotland’s national breast screening service is moving closer following an initial success with a trial project. While Scotland’s breast screening trial has delivered highs and lows, significant hurdles have been overcome in terms of approvals, governance and patient acceptance.
A new deep learning system to help radiologists improve their workflow efficiency when reading high volumes of screening mammograms is being developed at Johns Hopkins University’s Radiology Artificial Intelligence Lab (RAIL) in Baltimore, MD. DeepCAT (Deep Computer-Aided Triage) is focused on workflow prioritization.
Digital breast tomosynthesis (DBT) increases detection of breast cancer in symptomatic women under the age of 60, especially in dense breasts. A large, multi-institutional study conducted in the United Kingdom comparing the sensitivity of full-field digital mammography (FFDM), DBT, and FFDM plus DBT supports findings of two similar published studies, both conducted in China in the same time frame.
The impact of Covid-19 has been devastating; countless lives lost, millions of infections worldwide, health systems overwhelmed and economies rapidly shrinking. Screening, such as for breast or cervical cancer, is an area particularly affected, with numerous appointments delayed.
For many women, swollen lymph nodes are a red flag pointing to breast cancer – but may also be a normal immune reaction to a Covid-19 vaccination. In this Q&A, breast imaging experts address the most important facts on the topic.
AI can help tackle inequities and bias in healthcare but it also brings partiality issues of its own, experts explained in a Hot Topic session entitled "Artificial Intelligence and Implications for Health Equity: Will AI Improve Equity or Increase Disparities?" at RSNA.
Displaying medical images from different modalities such as CT, CR/DR, MR, ultrasound or mammography and pathology on one monitor - that is what most radiologists want. Many of them still use several medical displays next to each other. JVCKenwood's new CL-S1200 30.9-inch colour monitor makes this a thing of the past. The 12 megapixel device (4,200 horizontal and 2,800 vertical) can display…
Women with incident and proliferative benign breast diseases (BBD) are likelier to develop breast cancer, a Spanish researcher explained during the 12th European Breast Cancer Conference in October. These findings support the idea of designing personalised breast cancer screening strategies to improve effectiveness.
Tumours with the same biology have different prognoses based on their method of detection, and this information should be taken into account when deciding which treatments might be needed, a Dutch researcher explained at the 12th European Breast Cancer Conference.
A French expert in breast imaging looked at the latest Deep Learning (DL) applications in her field, screening their strengths and weaknesses in improving breast cancer detection. It is really important to understand which types of data sets need to be checked when evaluating an AI model for image interpretation, according to Isabelle Thomassin-Naggara, Professor of Radiology at Sorbonne…
The field of AI-enhanced imaging provides radiologists with an unprecedented opportunity to shape patient care, leading Austrian radiologist Katja Pinker-Domenig explained at ECR 2020.
Breast cancers that are detected in the interval between national screening programme mammograms have a worse prognosis than those detected at the time of a screening, even if they have the same biology, according to research presented at the 12th European Breast Cancer Conference. Analysis of results from over eight years’ follow-up of the international MINDACT randomised phase III clinical…
40 years ago, anticipating the huge impact of computers in radiology, a group of visionaries formed the Radiology Information System Consortium (RISC). In 1989, RISC created the Society for Computer Applications (SCAR) to promote computer applications in digital imaging. Those organisations became the Society for Imaging Informatics in Medicine (SIIM). At SIIM 2020, a virtual meeting, experts…
Researchers have developed the first blood test that can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms of the disease. In a paper published in the leading cancer journal Annals of Oncology, the researchers show that the test, which could eventually be used in national cancer screening…
Examining the safety of AI integration into clinical workflow during at the British Institute of Radiology (BIR) annual congress in London, this November, Professor Nicola Strickland focused on issues of data quantity and quality, regulation, validation and testing of algorithms. She also urged radiologists and computer scientists to work more closely together to develop safe, effective and…
A computer algorithm has been shown to be as effective as human radiologists in spotting breast cancer from x-ray images. The international team behind the study, which includes researchers from Google Health, DeepMind, Imperial College London, the NHS and Northwestern University in the US, designed and trained an artificial intelligence (AI) model on mammography images from almost 29,000 women.…
Although breast cancer (BC) mammography screening enables early detection of breast cancer, mammography presents issues such as variability between the radiology readings and shortage of radiologists. This area of medical imaging is where artificial intelligence (AI) could help make the biggest difference and improve patient outcome.
A new, portable breast imaging system under development in Buffalo has the potential to better identify breast cancer in women with dense breast tissue. That is among the findings of a study published in the journal IEEE Transactions on Biomedical Engineering. The study was led by University at Buffalo researchers in collaboration with Roswell Park Comprehensive Cancer Center and Windsong…
Breast cancer is rare for women under 40. So, a breast cancer diagnosis can be shocking news for a young woman to hear. “Breast cancer in young women can have its own risk factors and traits, and young women have their own considerations when deciding on a treatment,” says Nadine Tung, MD, head of breast medical oncology and cancer genetics at Beth Israel Deaconess Medical Center (BIDMC).…
The U.S. Food and Drug Administration (FDA) announced important new steps to modernize breast cancer screening and help empower patients with more information when they are considering important decisions regarding their breast health care. For the first time in more than 20 years of regulating mammography facilities, the agency is proposing amendments to key regulations that would help improve…
MRI offers unequalled sensitivity and specificity in breast cancer detection. Yet, it is poorly accepted preoperatively. Recently, eminent radiologist Francesco Sardanelli, professor for radiology at Milan University and Chief of Radiology at the IRCCS Policlinico San Donato in Italy, unveiled preliminary results that could further MRI acceptance among multidisciplinary teams.
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails? That’s where Georgia Institute of Technology researchers believe their new open source decision support tool could come in. Using machine learning to analyze RNA expression tied to…
Driving breast cancer screening compliance is an essential part of improving clinical outcomes, and one way to do this is to educate women about their breast density, advises Tracy Accardi, Hologic’s Global Vice President of Research and Development for Breast Health & Skeletal Solutions.
Tomosynthesis is under international review, with a surprising number of enticing studies carried out in Northern European countries, among them one headed by Professor Sophia Zackrisson at Lund University, Sweden. In our interview, she not only revealed surprising trial results, but also shared her thoughts on practical implementation and unusual speed-reading methods. ‘Our institute’s…
The UNESCO World Heritage City Bergen is seen as the gateway to the fiords of Norway. However, for radiologists the city offers an even more interesting attraction than Scandinavian landscapes. Bergen features one of the largest randomised control trials to compare digital breast tomosynthesis (DBT) with digital mammography (DM): the To-Be trial. Professor Solveig Hofvind, head of BreastScreen…
What beats digital mammography to detect breast cancer in asymptomatic women? Digital breast tomosynthesis (DBT) – was a big discussion at RSNA 2017. Sarah M Friedewald MD, medical director of the Lynn Sage Comprehensive Breast Center of Northwestern Memorial Hospital in Chicago and its division chief of breast and women’s imaging, discussed the clinical implications of DBT for routine…
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy as early as two weeks after beginning treatment. Findings from a first pilot study of the new imaging system—a noninvasive method of measuring blood flow dynamics in…
Half of cancers can be avoided if institutions would exchange knowledge, according to Joxel García, executive director of the University of Texas MD Anderson Cancer Center in Houston, who opened the Center’s meeting in Madrid in October 2016. Technology has progressed enormously and there has never been that much knowledge of cancer to prevent it and find treatment tools.
The use of deep learning (DL) technology could help radiologists increase the quality of breast cancer screening programs, lower costs, and reduce the variability in the cancer detection process. And the role of DL technology in imaging doesn't stop there. In fact, it is likely that DL computers can be trained to read mammograms as well as radiologists and — in the future — maybe even…
Scientists are using Artificial Intelligence (AI) to support more effective breast cancer detection. The researchers at Massachusetts Institute of Technology (MIT) Computer Science and Artificial Intelligence Laboratory (CSAIL), Massachusetts General Hospital (MGH), and Harvard Medical School, are using the machine learning system to predict whether breast lesions identified from a biopsy will…
Hologic, Inc. announced that it will provide all mammography systems for the Dutch Breast Cancer Screening Program in partnership with Tromp Medical, Hologic’s distributor in the Netherlands. Under the tender, Hologic’s new, state-of-the-art 3Dimensions mammography systems will be installed in mobile and stationary screening facilities across the country, starting in 2018. The multi-year…
A controversy regarding the benefit of early screening programmes for breast cancer continues. Germany, Austria and Switzerland have developed individual strategies. European Hospital asked three experts from these countries to outline each chosen system. Markus Hahn MD, senior consultant at the University Breast Centre in Tübingen, Martin Daniaux, MD, Head of Breast Diagnostics at the Breast…
‘Clinicians across Europe have made clear their desire for breast cancer screening technology that offers improved accuracy, clarity and workflow, and the 3Dimensions system addresses each of those specific areas,’ Hologic’s Jan Verstreken, Regional President for EMEA and Canada, pointed out during the launch of the new system. This is the latest in the firm’s breast cancer screening,…
Despite rigorous quality assurance of breast cancer screening programs, ‘both, over- and under-diagnosis of breast cancer is a challenge,’ says leading radiologist Christiane K Kuhl, from the Department of Diagnostic and Interventional Radiology, at the University of Aachen, Germany. ‘Mammography is a good screening test – but has its limitations especially, but not only, in women with…
In a potential major breakthrough in breast cancer research, scientists at the Center for Translational Cancer Research (CTCR) at the Helen F. Graham Cancer Center & Research Institute of Christiana Care Health System have developed a revolutionary new blood test to diagnose breast cancer.
Hologic, Inc. announced that the 3Dimensions mammography system, the fastest, highest resolution breast tomosynthesis system ever, is available for purchase in Europe. The new product is the latest addition to Hologic's portfolio of market-leading breast cancer screening, diagnostic and interventional solutions. It offers a variety of groundbreaking features designed to provide higher quality 3D…
Dr Massimo Calabrese, head of the Complex Operative Unit of Diagnostic Senology in Genoa’s San Martino Hospital, examines aspects of stereotactic breast biopsy procedures and workflow and the need for improvements in certain areas of breast diagnostics.
Biannual mammography can help to reduce breast cancer mortality by 40% in women aged 50-69, but the benefits for women under 35 years old are questionable, eminent Spanish radiologists highlighted during a session held by SERAM, their national society of radiology, last November, during the International Radiology Day.
The University of Southern California (USC) Norris Comprehensive Cancer Center is actively recruiting for a clinical trial that is researching the effectiveness of a breath test for breast cancer diagnostics. The BreathLink device, manufactured by Menssana Research, Inc., captures a two-minute sample of a patient’s breath and provides immediate results on whether there are indications of breast…
The job title radiographer has a firm place in many European and non-European countries. The academic training reflects the complex range of responsibilities the role entails.
Radiologists and radiographers all over the world will once again celebrate the International Day of Radiology (IDoR) on November 8, which this year takes breast imaging as its main theme. The IDoR is an initiative of the European Society of Radiology (ESR), the American College of Radiology (ACR) and the Radiological Society of North America (RSNA).
Italian-led research has highlighted the value of utilising additional screening technologies to help diagnose breast cancer in some women. Interim analysis from the Adjunct Screening with Tomosynthesis or Ultrasound in Women with Mammography-Negative Dense Breasts (ASTOUND) study has delivered evidence of the potential benefit of adding either ultrasound or tomosynthesis to standard mammograms…
Preliminary tests have demonstrated that a new device may enable existing breast cancer imagers to provide up to six times better contrast of tumors in the breast, while maintaining the same or better image quality and halving the radiation dose to patients. The advance is made possible by a new device developed for 3D imaging of the breast by researchers at the Department of Energy's Thomas…
The ongoing debate about breast cancer diagnostics has left many women confused — particularly over what age they should get mammograms and who needs treatment. An issue with current methods is that they often identify lumps but cannot conclusively pinpoint which ones are cancerous. To help resolve this uncertainty, researchers have developed a pill that could improve imaging techniques so that…
Results from recent trials are promising: an almost 40% increased breast cancer detection rate from digital breast tomosynthesis (DBT) screening compared to conventional mammography.
A new EU-funded project HYPMED is developing a ground-breaking imaging method for more accurate detection of breast cancer and a better, more personalised, understanding of its response to therapy.
In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced breast cancer for most women. However, the research showed increased risk for women with large breasts or breast implants, who must often receive extra screening views, increasing their radiation exposure.
A magnetic resonance (MR) breast imaging technique that uses no ionizing radiation or contrast agent could reduce unnecessary biopsies by providing additional information about suspicious findings on X-ray screening mammography, according to a new study published online in the journal Radiology.
Each year, approximately 1.6 million women in the USA have breast biopsies to diagnose or rule out cancer. Pathological diagnosis is considered the gold standard – how accurate are these diagnoses? Report: Cynthia E. Keen
Imaging tests like mammograms or CT scans can detect tumors, but figuring out whether a growth is or isn’t cancer usually requires a biopsy to study cells directly. Now results of a Johns Hopkins study suggest that MRI could one day make biopsies more effective or even replace them altogether by noninvasively detecting telltale sugar molecules shed by the outer membranes of cancerous cells.
It is tough enough to be a clinician reading dozens of mammograms every day to detect early signs of breast cancer. Now those same radiologists must become statisticians in order to decrypt dozens of studies, challenging whether it is worth reading mammograms in the first place. Report: John Brosky
Women over the age of 50 are not only at higher risk of developing breast cancer but also osteoporosis. Would it not be practical to use the same method to detect both diseases early on? Definitely, decided Sectra, the Swedish company specialising in PACS and mammography systems.
The Koning Breast CT (KBCT) system, which has been granted FDA approval, provides 3D breast of the entire breast from any orientation for diagnoses.
At the recent North American IHE Connectathon in Cleveland, Sectra (STO: SECT B) successfully completed testing of the IHE profiles MAMMO and DBT (Digital Breast Tomosynthesis). The testing was done using Sectra PACS which implements the Image Display and Image Manager actors of these profiles.
Carestream will show enhancements to its digital breast tomosynthesis (DBT) module including a slabbing tool, improved workflow capabilities and the display of DICOM-compliant 2D synthetic views (which are generated from the 3D dataset) at the 2015 European Conference of Radiology. The latest DBT module is currently available.
Among new medical imaging innovations is a phase-contrast x-ray technique to bring greater precision to breast cancer assessment and improve biopsy diagnostics. EH asked research pioneer Professor Marco Stampanoni, a key figure in the development of this technique, to explain how it works. Report: Sascha Keutel
Why is early detection of breast cancer so important? Professor Dr Walter Heindel, Director of the Institute of Clinical Radiology at University Hospital Münster, Germany, offers an unequivocal answer.
Within many exhibitors’ booths at the RSNA, mobile computing devices are in use, a sales tool augmenting the vendor’s display. They are like bunnies running rampant. They are proliferating, and their intelligent use is aiding complex sales presentations.
Breast cancer hurt her but after a long treatment, she is now 10 years past the day she heard "You have cancer."
It may well be the first computer-aided detection (CAD) software that went to school with radiologists to study breast cancer.
In May, 2013, the U.S. Food and Drug Administration (FDA) finally took the training wheels off tomosynthesis by approving the use of Hologic's new C-View 2D imaging in place of conventional 2D mammograms previously required as part of a breast tomosynthesis screening exam.
Dr Martínez Miravete didn’t set out to change breast imaging in Spain when she first adopted breast tomosynthesis.
Over the decades of breast imaging numerous studies have shown that radiation free and inexpensive ultrasound can detect some subtle cancers not visible on a mammography exam.
Dr. Paula Martínez Miravete didn’t set out to change breast imaging in Spain when she first adopted breast tomosynthesis.
New business ventures, new systems – and those include 3-D mammography
You won't find a single new machine among the novel technology shaping radiology. Instead software, not hardware, is the key that is opening new frontiers.
With 350,000 mammography screenings annually, Unilabs Sweden finds itself on the leading edge for research in mammography and pioneering patient education programmes. John Brosky reports
Philips is showcasing the company’s mission of “Transforming Care Together” by featuring several of its latest solutions developed with customer insights in mind, demonstrating the company’s commitment to keeping pace with the changing needs of radiologists at RSNA.
Carestream will demonstrate top of the edge technologie and launches digital breast tomosynthesis module for its Vue Mammo Workstation on booth 2636 in Chicago.
Study suggests a new method to measure breast density can help determine cancer risk
In Europe, 350,000 women are diagnosed with breast cancer annually. About 90% of them can be cured if the cancer is detected at a very early stage. To improve early detection almost all European countries have gradually initiated regional screening programmes, even though the benefits are discussed controversially from time to time.
Two years ago Dr Michael Michell and team at King’s College Hospital, London, set out to explore the benefits of tomosynthesis over conventional 2-D mammography. Their study has shown advantages in diagnostic accuracy and indicates that tomosynthesis could help to reduce the number of patient recalls for further examination and thus anxiety among women.
No imaging modality is infallible -- not even mammography, the golden standard for early detection of breast cancer. Particularly in women with dense breast tissue, the diagnostic quality of conventional mammography frequently suffers in terms of sensitivity and specificity. However, the evolution of digital systems has produced technologies that optimise sensitivity as well as specificity and…
From first lady of breast MRI to the Germany’s most influential woman in radiology – that’s one way to describe Professor Christiane Kuhl’s switch from being Vice-Chairman of the Department of Radiology and Vice President of the University of Bonn to become Chairman of the Department of Diagnostic and Interventional Radiology at the University Hospital Aachen (UKA).
ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, today introduced two innovative solutions at the 2011 European Congress of Radiology (ECR). A mammography solution addresses current limitations of x-ray image diagnosis for the detection of breast cancer, while the interventional radiology solution helps achieve superior, real-time images…
SECure TRAnsmission, the main aim of a spin-off from the Linköping Institute of Technology, was established in 1978. From this beginning, the Swedish firm Sectra has evolved into one of the world’s leading players in PACS and mammography solutions. Although secure communication systems remains a core business, the medical section has constantly grown since 1988, when Dr Torbjörn Kronander…
It’s digital mammography taken to the next level – or, so to speak, the next dimension as digital breast tomosynthesis (DBT) that provides high resolution 3-D imaging. For about two years this exciting technology has promised to become the magic bullet in the early detection of breast cancer, particularly in the dense breast.
Digital breast tomosynthesis (DBT) is a promising new technology that acquires 3-dimensional images of the breast. The individual images are presented as thin high-resolution slices that can be displayed individually or in a dynamic cine mode. Preliminary studies in a clinical setting have demonstrated that this new technology has the potential to improve not only the detection of breast cancers…
White nights in St Petersburg draw in not only romantics, but June in this beautiful city also sees thousands of delegates arrive to attend the many scientific conferences and congresses. Among oncologists, the ‘white nights’ period means another annual scientific conference organised by the NN Petrov Research Institute of Oncology. For its continuing focus on breast cancer, the halls are…
A study looking at breast cancer patients in England compared to those in Norway and Sweden has highlighted the importance of early detection. The three-country comparison reveals that every year almost 1,000 more lives could be saved in England alone.
The Swedish IT and medical-technology company Sectra has been awarded a contract to install four MicroDose Mammography units for use in Victoria. The Sectra MicroDose units offer improved or identical image quality at a lower radiation dose than other solutions in the market.
The overall success of MRI in diagnosing breast cancer and the exploding demand for breast MRI, in particular, have caused a scanner shortage in much of Europe. Dr Jean-Pierre Pruvo, Chairman of the French Society of Radiology, recently raised the alarm: ‘We have hundreds of thousands of women in France at risk for breast cancer, yet we do not have the means to provide a breast examination by…
At the European Congress of Radiology (ECR) 2010 in Vienna, Siemens Healthcare presented its innovative ultrasound solutions. The highlight this year was the new release of its premium Acuson S2000 ultrasound system featuring significant advancements in ARFI technology (Acoustic Radiation Force Imaging) for the detection and quantification of tissue. Combined with a 3D breast volume scanner…
Digital mammograms deliver an average of 22% less radiation than film mammograms, according to a study partially funded by the National Cancer Institute and published in the American Journal of Roentgenology, Reuters reports. For the study, researchers analyzed the results of the 2005 Digital Mammographic Imaging Screening Trial involving 49,528 women. That trial found that digital mammograms…
Members of a Syracuse University research team in the USA have shown that an obscure phenomenon called stochastic resonance (SR) can improve the clarity of signals in systems such as radar, sonar and even radiography, used in medical clinics to detect signs of breast cancer. It does this by adding carefully selected noise to the system.
Targeted breast ultrasound of suspicious areas of the breast, including lumps, is a safe, reliable and cost-effective alternative to invasive biopsies for women under age 40, according to the findings of two new studies presented.
There's no reason to forgo a needed radiation-based medical procedure because of concerns about cancer risk, according to the October issue of Mayo Clinic Health Letter. While the volume of radiation-based tests and procedures has increased in the past three decades, scientists haven't proven that the low doses of radiation used in medical settings actually increase cancer risk.
Digital mammography, which is considered the gold standard of breast imaging, has rendered image management and consequently the entire – purely on-screen – diagnostic process more reliable and more efficient.
Real-time Tissue Elastography, an ultrasound procedure that uses colour to differentiate clearly and unambiguously between malignant, hardened tissue and flexible, benign tissue could be the addition needed to have really effective breast cancer screening, according to independent radiologist, and specialist in Real-time Tissue Elastography Dr Bruno Scheffer from Nantes, France.
Although breast cancer, the most common disease affecting women, accounts for over 30% of all the cancers they suffer (far ahead of colon, ovary or lung cancer), breast cancer is responsible for only 1% of cancer related deaths.
Analogue screening systems are gradually being replaced by digital mammography systems, and breast cancer screening programmes are increasing sales. The majority of European countries have implemented in European countries, but in some others their introduction is slow, but steady. Additionally, Europe has significant geographic diversity, and remote places served by mobile screening units…
It is not only the examination itself that makes mammography screening programmes successful, an intelligent integration of the data into the hospital´s RIS is another integral part of it. Since last year, a new mammography module for the Carestream RIS, is improving mammography screening administration in three of Denmark's five regions. Development work on the innovative module was initiated…
Delegates at the 2009 European Congress of Radiology (ECR) saw a series of presentations Friday unveiling new findings and key updates on digital breast tomosynthesis (DBT). As the body of research builds in this relatively unexplored field, the advantages and limitations of DBT compared with conventional full-field digital mammography (FFDM) and other modalities are becoming better defined.
Dr Giorgio Rizzatto, who heads the Department of Diagnostic Imaging at ASS 2 Isontina (including the Gorizia and Monfalcone hospitals) in NE Italy, works with nine radiologists, who examine and report on 80,000 clinical and screening breast examinations annually.
The Dutch screening programme, which began in 1990, invites women aged 50-75 years for mammography screening every two years. Today, the national programme is undergoing considerable regional re-organisation. As one of a team of 12 radiologists at the Alkmaar Medical Centre, Dr Shirley Go is responsible for Mammography and Screening in a large Dutch region. Daniela Zimmermann, asked Dr Go about…
SecondLook Digital from iCAD is Philips' new computer aided detection solution for early breast cancer detection. It supports physicians in identifying and marking suspicious areas. The software performs optimally with both Philips DR and CR mammography solution and seamlessly integrates in Philips PACS and Philips viewing workstation MammoDiagnost VU.
Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
The use of mammography to maintain breast health comes with a caveat: exposure of the breast to radiation, which can increase the susceptibility risk of breast cancer. Thus, using the lowest possible radiation dose for mammograms is of utmost importance.
In a pre-conference discussion with this year's President, Professor Hans-Heinrich Kreipe, Director of the Institute for Pathology at Hanover Medical School, he outlined the significance of MRI in breast cancer detection, and highlighted other topics for the event.
It is safe to take anticoagulants before core needle breast biopsies, according to a study performed at the Elizabeth Wende Breast Clinic in Rochester, NY.
Double reading is better than single reading - at least for the detection of small breast cancer. But a software could boost one readers functionality. UK-researchers found out that performance of a single reader using a computer-aided detection system may match the performance achieved by two readers.
Fighting breast cancer is always a race against time - early detection of breast carcinoma an essential condition for cure. Now Scientists from Finland, Germany and France developed a promising new CT technique with high resolution and contrast that visualises tumours that are even diffusely growing or those in dense breasts.
More than 250,000 women under the age of forty are living with the disease in the US and 11,000 will be diagnosed in the next year. Even so, young women are underrepresented in many research studies and treatments, according to genomic expert Simon Chin.
Researchers compared the Norwegian organised population based mammogram screening every second year and a physician- or self-referrals annual test in the US. Both are equally sensitive, but the recall rate for abnormal results was lower in Norway.
It sounds impressively simple: An over-the-counter pain-relieving gel from the drugstore may reduce the uncomfortable and even dolorous feeling women experience during mammography exams, according to the a study published in the online edition of Radiology.
Since decades women carefully feel their breast. Hoping that they will not find any evidence for lumps or other changes, that might signal breast cancer. However, a review of recent studies conclude that self-exams do not appear to reduce deaths. Whereas radiation therapy may lower recurrence rate of rare breast cancer.
While in Europe experts still discuss whether mammography screening is the ideal tool to save women from breast cancer, the Wall Street Journal investigated if mammography is really enough. Physicians claim that women with higher risk to develop breast carcinoma should receive MRI or ultrasound.
At the DRK Congress (Deutscher Röntgenkongress, 30 April - 3 May, in Berlin, Carestream Healthcare will introduce its new digital radiography and computed radiography systems, including the DirectView DR 9500 System, the DR 3500 System, as well as its latest single-cassette CR products, DirectView CR Elite and the new Kodak Point-of-Care CR 360.
Breast cancer morbidity has been the leading oncology disease (21.8%) in Russia since 1996 - and since 1981 in St. Petersburg. In Moscow, the morbidity has increased 52.4% in last 14 years.
A study recently published in the online version of the American Journal of Roentgenology evaluated the clinical value of Computer-Aided Detection (CAD) software in the interpretation of mammograms. In the course of the study, the recall rate, sensitivity, positive predictive value, and cancer detection rate for single reading with CAD, versus double reading without CAD, were investigated.
A promising mammography screening technology By Andrew Smith PhD, principal scientist at Hologic, Inc. in Bedford, Mass, is involved in research and development of digital imaging systems.
For women with breast symptoms such as lumps, the ability of diagnostic mammograms to detect breast cancer accurately depends strongly on which radiologist reads them, according to a Group Health study published online Dec. 11 in the Journal of the National Cancer Institute.
It is hoped that a new technology, digital breast tomosynthesis or 3-D mammography, will overcome three drawbacks of traditional screening mammography: discomfort with breast compression, cancer concealed within overlapping tissue and the limited number of views.
The first 15 megapixels display, which enables radiologists to monitor two mammograms on one screen, was launched at RSNA 2007 by the Japanese firm Totoku.
Brenda Marsh reports on the country's flourishing and expanding breast screening programme
Radiologists frequently have limited time when examining mammography images, especially under screening conditions. In addition to their training and experience, the computer can offer beneficial support in the detection of breast cancer, due to special Computer Aided Detection (CAD) software solutions
Dr Eduardo de la Sota reports
X-ray based mammograms detect only 56% of early lesions in high risk women compared with 92% when MRI scanning (mostly used for brain scans), according to a study by Christiane Kuhl and colleagues at the University of Bonn (pub: the Lancet. 8/07).
Australia - The Australian Institute of Health and Welfare has reported a 26% decrease in the breast cancer mortality rate among women aged 50-69 years between 1990 and 2004.
Combining a scientific research laboratory with specialised clinic, the Netherlands Cancer Institute, in the Antoni van Leeuwenhoek Hospital (NKI-AVL), in Amsterdam, aims for a unique interaction of scientific research and clinical application.
USA - Web-based mail and phone reminder software significantly increased the percentage of patients who received preventive health services, according to a study led by Rajeev Chaudhry MBBS, at the Mayo Clinic, published in May in The Archives of Internal Medicine.
USA - A steep drop in breast cancer rates between 2002 and 2003 correlates with the decline in hormone therapy use, according to research froma the American Cancer Society (ACS).
2D imaging - whether analogue or digital - is thought to miss detection of 20-30% of breast cancers. Early clinical results from studies using the new technology tomosynthesis indicate its potential to lower those percentages.
Full field digital mammography (FFDM) and computed radiography (CR) based mammography systems may bring hospitals and breast imaging services closer to gaining digital mammography, but, according to a leading systems vendor, simply buying imaging equipment does not automatically lead to a more efficient workflow.
By Thomas Mertelmeier, Principal Scientist at Siemens AG Medical Solutions
In Ireland, breast cancer is particularly virulent: 18.5% of all cancer related deaths among the women are due to breast cancer.
20% of all cancers diagnosed annually among Lithuanian women is cancer of the breast. Screening programms should reduce this number.
A report by Keith Halson, our correspondent in France.
Guidelines updated for high-risk women aged between 20-49 years.
USA - Radiologists at Newton-Wellesley Hospital in Newton, Massachusetts have released findings from a breast cancer research study designed to evaluate the use of software from Advanced Image Enhancement, Inc (AIE) for examining regions of interest (ROI) with Hologic's Lorad Selenia digital mammography system.
Cynthia E Keen discusses the controversy evoked by an ambitious 36-month digital mammography trial that has cost the US $26,000,000
Germany's Federal Committee of Physicians and Statutory Health Insurance Funds set up three model projects, based in Bremen, Wiesbaden and Weser-Ems, to trial the third edition of the European guidelines on healthcare within the German system and to develop the necessary organisational structures to make these work.
Financed by the Ministry of Health, nine regional screening organisations arrange and implement the Dutch national breast cancer screening programme, in which, every two years, all women from 50-75 years of age are invited for a free mammogram at one of the 62 screening points, of which 56 are mobile vans.
Mammography plays a critical part in diagnosing breast cancer. Although this does not prevent the disease, diagnosing breast cancer as early as possible can save lives.
Mammography as a diagnostic procedure to evaluate detected tumours is not an issue. But because the technique is performed, in screening programmes, on apparently healthy people, for ethical reasons it becomes an issue.
Interviewed by Daniela Zimmermann, Executive Director of EH, Jean Hooks, General Manager, Global Mammography at GE Healthcare, examined reasons behind the slow uptake of digital technology in some European countries, comparing this with its early adoption in the USA
